article thumbnail

UK : House of Commons Library – Research Briefing – Debate on access to psilocybin treatments – Published Thursday, 18 May, 2023

Cannabis Law Report

A debate has been scheduled for 18 May on access to psilocybin treatments. Documents to download Commons Library debate pack – Access to psilocybin treatments […]

article thumbnail

Marijuana Legalization Linked to Decline in Youth Drug Treatment Admissions

CannaMD

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Colorado and Washington were the first states to legalize recreational cannabis use in 2012.

Treatment 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Press Release: Ixtlan Bioscience Announces the Filing of New Patent for the Psilocybin Treatment of Alzheimer’s Disease and Brain Pathologies

Cannabis Law Report

21, 2021 /PRNewswire/ — Ixtlan Bioscience , a biotech company focused on developing psilocybin-based treatment for Alzheimer’s Disease and Brain Pathologies, has announced today the filing of a new Provisional Patent with the United States Patent and Trademark Office (USPTO) Application No. TEL AVIV, Israel , Dec.

article thumbnail

CannaMD Partners with Releaf App: Tracking Patient Outcomes

CannaMD

You can download the Releaf App for free by visiting the Apple App Store or Google Play. CannaMD patients are encouraged to track their medical cannabis experiences by downloading the Releaf app with group code “cannamd.” Patients can learn more by visiting ReleafApp.com. CannaMD Patients: Getting Started. Get Started.

article thumbnail

CBD Market Report

Project CBD

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144
article thumbnail

The Complete Guide To Iowa MMJ Laws

MMJ Recs

With a growing recognition of its potential therapeutic benefits, Iowa has established a medical marijuana program to provide eligible patients with access to cannabis-based treatments. The Iowa medical marijuana program represents a significant step forward in providing patients with alternative treatment options.

Law 52
article thumbnail

Parallel Separates the Chairman and CEO Roles

Cannabis Law Report

Parallel has ongoing operations in five medical and adult-use markets under the retail brands of Surterra Wellness in Florida ; goodblend in Texas and in Pennsylvania ; New England Treatment Access (NETA) in Massachusetts , and a joint venture with Cookie’s retail brand in Nevada. SOURCE Parallel.

Retail 52